GSK-204851

Study Sponsor: GSK

Study Title

A multi-centre Phase IIa double-blind, placebo-controlled study to investigate the efficacy and safety of GSK3196165 in subjects with inflammatory hand osteoarthritis

Medicine or Vaccine (generic name)

otilimab

Sponsor Identification Number

204851

Trial Registry Identification Number(#'s)

NCT02683785

Medical Condition

Osteoarthritis

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=204851

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02683785

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2015-003089-96

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format.

Date Added to this Site

November 2020